Acuta Capital Partners, LLC Top Holdings and 13F Report (2024) About Acuta Capital Partners, LLCInvestment ActivityAcuta Capital Partners, LLC has $123.46 million in total holdings as of September 30, 2024.Acuta Capital Partners, LLC owns shares of 41 different stocks, but just 17 companies or ETFs make up 80% of its holdings.Approximately 25.18% of the portfolio was purchased this quarter.About 36.94% of the portfolio was sold this quarter.This quarter, Acuta Capital Partners, LLC has purchased 33 new stocks and bought additional shares in 11 stocks.Acuta Capital Partners, LLC sold shares of 12 stocks and completely divested from 8 stocks this quarter.Largest Holdings Vaxcyte $15,472,158Ocular Therapeutix $10,353,618TOURMALINE BIO INC $8,538,162Insmed $7,847,500Enliven Therapeutics $7,569,239 Largest New Holdings this Quarter Ascendis Pharma A/S $3,135,510 HoldingCOMPASS Pathways $2,434,950 HoldingAcelyrin $1,794,520 HoldingEdgewise Therapeutics $1,681,470 HoldingGilead Sciences $1,634,880 Holding Largest Purchases this Quarter Ascendis Pharma A/S 21,000 shares (about $3.14M)Vaxcyte 25,000 shares (about $2.86M)Insmed 35,400 shares (about $2.58M)COMPASS Pathways 386,500 shares (about $2.43M)Mereo BioPharma Group 583,700 shares (about $2.40M) Largest Sales this Quarter Ocular Therapeutix 1,581,059 shares (about $13.76M)PRAXIS PRECISION MEDICINES I 106,931 shares (about $6.15M)DYNE THERAPEUTICS INC 166,300 shares (about $5.97M)Enliven Therapeutics 101,330 shares (about $2.59M)Revolution Medicines 25,000 shares (about $1.13M) Sector Allocation Over TimeMap of 500 Largest Holdings ofAcuta Capital Partners, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorPCVXVaxcyte$15,472,158$2,856,750 ▲22.6%135,40012.5%MedicalOCULOcular Therapeutix$10,353,618$13,755,214 ▼-57.1%1,190,0718.4%MedicalTOURMALINE BIO INC$8,538,162$1,606,386 ▲23.2%332,0956.9%COMINSMInsmed$7,847,500$2,584,200 ▲49.1%107,5006.4%MedicalELVNEnliven Therapeutics$7,569,239$2,587,968 ▼-25.5%296,3686.1%MedicalCRNXCrinetics Pharmaceuticals$6,729,870$175,835 ▼-2.5%131,7005.5%MedicalACLXArcellx$5,185,971$1,661,849 ▲47.2%62,1004.2%MedicalMREOMereo BioPharma Group$5,181,477$2,399,007 ▲86.2%1,260,7004.2%MedicalRVMDRevolution Medicines$4,897,800$1,133,750 ▼-18.8%108,0004.0%MedicalTSHATaysha Gene Therapies$4,259,174$426,009 ▼-9.1%2,118,9923.4%MedicalTERNTerns Pharmaceuticals$4,061,580$981,785 ▲31.9%487,0003.3%MedicalKURAKura Oncology$3,849,380$664,360 ▲20.9%197,0003.1%MedicalAADIAadi Bioscience$3,809,7680.0%1,849,4023.1%MedicalRCKTRocket Pharmaceuticals$3,509,300$1,115,034 ▼-24.1%190,0002.8%MedicalPRAXIS PRECISION MEDICINES I$3,308,550$6,152,810 ▼-65.0%57,5002.7%COMARGXargenx$3,198,272$1,029,952 ▲47.5%5,9002.6%MedicalASNDAscendis Pharma A/S$3,135,510$3,135,510 ▲New Holding21,0002.5%MedicalCMPSCOMPASS Pathways$2,434,950$2,434,950 ▲New Holding386,5002.0%MedicalMRSNMersana Therapeutics$2,268,000$875,070 ▼-27.8%1,200,0001.8%MedicalHELIX ACQUISITION CORP II$1,890,857$32,489 ▲1.7%180,9451.5%CL A ORD SHSSLRNAcelyrin$1,794,520$1,794,520 ▲New Holding364,0001.5%MedicalEWTXEdgewise Therapeutics$1,681,470$1,681,470 ▲New Holding63,0001.4%MedicalDYNE THERAPEUTICS INC$1,659,504$5,973,496 ▼-78.3%46,2001.3%COMGILDGilead Sciences$1,634,880$1,634,880 ▲New Holding19,5001.3%MedicalRAREUltragenyx Pharmaceutical$1,394,305$1,394,305 ▲New Holding25,1001.1%MedicalTRVITrevi Therapeutics$970,270$101,870 ▲11.7%290,5000.8%MedicalUNCYUnicycive Therapeutics$807,315$807,315 ▲New Holding1,979,1990.7%MedicalLQDALiquidia$735,000$735,000 ▲New Holding73,5000.6%MedicalVERVVerve Therapeutics$707,124$707,124 ▲New Holding146,1000.6%MedicalGERNGeron$703,246$703,246 ▲New Holding154,9000.6%MedicalCELCCelcuity$694,806$23,856 ▲3.6%46,6000.6%MedicalARTIVA BIOTHERAPEUTICS INC$679,800$679,800 ▲New Holding44,0000.6%COMTECTONIC THERAPEUTIC INC$415,110$415,110 ▲New Holding13,7000.3%COMCRBPCorbus Pharmaceuticals$381,655$948,980 ▼-71.3%18,5000.3%MedicalRAPPORT THERAPEUTICS INC$360,448$49,152 ▼-12.0%17,6000.3%COMLPTXLeap Therapeutics$309,685$191,465 ▼-38.2%120,5000.3%MedicalELYMEliem Therapeutics$274,860$274,860 ▲New Holding54,0000.2%MedicalBENITEC BIOPHARMA INC$273,862$273,862 ▲New Holding29,8000.2%COM NEWTVTXTravere Therapeutics$265,810$265,810 ▲New Holding19,0000.2%MedicalTHRDTF Financial$210,133$210,133 ▲New Holding15,5080.2%MedicalNUVATION BIO INC -CW27$8,8920.0%90,8320.0%*W EXP 07/07/2027SRPTSarepta Therapeutics$0$4,345,000 ▼-100.0%00.0%MedicalAGIOAgios Pharmaceuticals$0$3,393,544 ▼-100.0%00.0%MedicalVRDNViridian Therapeutics$0$2,594,623 ▼-100.0%00.0%MedicalORICORIC Pharmaceuticals$0$678,720 ▼-100.0%00.0%MedicalPLRXPliant Therapeutics$0$496,650 ▼-100.0%00.0%MedicalNAMSNewAmsterdam Pharma$0$432,225 ▼-100.0%00.0%MedicalCLRBCellectar Biosciences$0$176,250 ▼-100.0%00.0%MedicalSVRASavara$0$100,750 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
